1. Home
  2. RLMD vs FGF Comparison

RLMD vs FGF Comparison

Compare RLMD & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • FGF
  • Stock Information
  • Founded
  • RLMD 2004
  • FGF 2012
  • Country
  • RLMD United States
  • FGF United States
  • Employees
  • RLMD N/A
  • FGF N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • FGF Property-Casualty Insurers
  • Sector
  • RLMD Health Care
  • FGF Finance
  • Exchange
  • RLMD Nasdaq
  • FGF Nasdaq
  • Market Cap
  • RLMD 22.0M
  • FGF 20.2M
  • IPO Year
  • RLMD N/A
  • FGF N/A
  • Fundamental
  • Price
  • RLMD $0.83
  • FGF $16.89
  • Analyst Decision
  • RLMD Hold
  • FGF
  • Analyst Count
  • RLMD 4
  • FGF 0
  • Target Price
  • RLMD $4.25
  • FGF N/A
  • AVG Volume (30 Days)
  • RLMD 840.1K
  • FGF 1.9K
  • Earning Date
  • RLMD 05-12-2025
  • FGF 05-14-2025
  • Dividend Yield
  • RLMD N/A
  • FGF N/A
  • EPS Growth
  • RLMD N/A
  • FGF N/A
  • EPS
  • RLMD N/A
  • FGF N/A
  • Revenue
  • RLMD N/A
  • FGF $13,260,000.00
  • Revenue This Year
  • RLMD N/A
  • FGF N/A
  • Revenue Next Year
  • RLMD N/A
  • FGF N/A
  • P/E Ratio
  • RLMD N/A
  • FGF N/A
  • Revenue Growth
  • RLMD N/A
  • FGF N/A
  • 52 Week Low
  • RLMD $0.24
  • FGF $14.21
  • 52 Week High
  • RLMD $4.47
  • FGF $38.40
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 72.41
  • FGF 53.59
  • Support Level
  • RLMD $0.65
  • FGF $15.95
  • Resistance Level
  • RLMD $0.77
  • FGF $18.73
  • Average True Range (ATR)
  • RLMD 0.10
  • FGF 0.43
  • MACD
  • RLMD 0.02
  • FGF 0.06
  • Stochastic Oscillator
  • RLMD 86.00
  • FGF 37.41

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About FGF FG Financial Group Inc. (NV)

Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segments includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.

Share on Social Networks: